Pemetrexed

Product NDC
0480-4516
11-digit product format
004804516
Labeler code
0480
Product ID
0480-4516_21155bd2-118e-4ce6-adb8-dddc69ae34c7
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Pemetrexed
Dosage form
SOLUTION, CONCENTRATE
Route
INTRAVENOUS
Labeler
Teva Pharmaceuticals, Inc.
Application
NDA208419
Marketing category
NDA
Marketing start
2022-06-01
Substance
PEMETREXED MONOHYDRATE
Active strength
25 mg/mL
Pharmacologic classes
Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N208419-001PEMETREXEDPEMETREXED100MG/4ML (25MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-08-21
N208419-002PEMETREXEDPEMETREXED500MG/20ML (25MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-08-21
N208419-003PEMETREXEDPEMETREXED1GM/40ML (25MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-08-21

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 114 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-18 06:07:402026-07N208419-001PEMETREXED100MG/4ML (25MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-08-21caaa826d4ba7…
2026-08-18 06:07:402026-07N208419-002PEMETREXED500MG/20ML (25MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-08-21caaa826d4ba7…
2026-08-18 06:07:402026-07N208419-003PEMETREXED1GM/40ML (25MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-08-21caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N208419-001PEMETREXED100MG/4ML (25MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-08-21011fe1cb6892…
2026-02-19 14:30 UTC2026-02N208419-002PEMETREXED500MG/20ML (25MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-08-21011fe1cb6892…
2026-02-19 14:30 UTC2026-02N208419-003PEMETREXED1GM/40ML (25MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-08-21011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N208419-001PEMETREXED100MG/4ML (25MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-08-2131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N208419-002PEMETREXED500MG/20ML (25MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-08-2131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N208419-003PEMETREXED1GM/40ML (25MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-08-2131067a03dcf5…
2025-08-23 18:47 UTC2025-08N208419-001PEMETREXED100MG/4ML (25MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-08-216a471c1ec25d…
2025-08-23 18:47 UTC2025-08N208419-002PEMETREXED500MG/20ML (25MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-08-216a471c1ec25d…
2025-08-23 18:47 UTC2025-08N208419-003PEMETREXED1GM/40ML (25MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-08-216a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N208419-001PEMETREXED100MG/4ML (25MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-08-21fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N208419-002PEMETREXED500MG/20ML (25MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-08-21fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N208419-003PEMETREXED1GM/40ML (25MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-08-21fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N208419-001PEMETREXED100MG/4ML (25MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-08-21b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N208419-002PEMETREXED500MG/20ML (25MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-08-21b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N208419-003PEMETREXED1GM/40ML (25MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-08-21b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N208419-001PEMETREXED100MG/4ML (25MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-08-2103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N208419-002PEMETREXED500MG/20ML (25MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-08-2103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N208419-003PEMETREXED1GM/40ML (25MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-08-2103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N208419-001PEMETREXED100MG/4ML (25MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-08-212680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N208419-002PEMETREXED500MG/20ML (25MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-08-212680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N208419-003PEMETREXED1GM/40ML (25MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-08-212680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N208419-001PEMETREXED100MG/4ML (25MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-08-215bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N208419-002PEMETREXED500MG/20ML (25MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-08-215bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N208419-003PEMETREXED1GM/40ML (25MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-08-215bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N208419-001PEMETREXED100MG/4ML (25MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-08-21d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N208419-002PEMETREXED500MG/20ML (25MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-08-21d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N208419-003PEMETREXED1GM/40ML (25MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-08-21d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N208419-001PEMETREXED100MG/4ML (25MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-08-21d06236e962d9…
2024-10-29 15:01 UTC2024-10N208419-002PEMETREXED500MG/20ML (25MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-08-21d06236e962d9…
2024-10-29 15:01 UTC2024-10N208419-003PEMETREXED1GM/40ML (25MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-08-21d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N208419-001PEMETREXED100MG/4ML (25MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-08-2179d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N208419-002PEMETREXED500MG/20ML (25MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-08-2179d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N208419-003PEMETREXED1GM/40ML (25MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-08-2179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N208419-001PEMETREXED100MG/4ML (25MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-08-21301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N208419-002PEMETREXED500MG/20ML (25MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-08-21301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N208419-003PEMETREXED1GM/40ML (25MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-08-21301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N208419-001PEMETREXED100MG/4ML (25MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-08-211e350fbaab3a…

Additional Listing Data#

Finished product
Yes
Brand name base
Pemetrexed
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
PEMETREXED MONOHYDRATE25 mg/mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
236Y2F7D9JInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 3 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
2602363Internal RxNorm lookup
2602365Internal RxNorm lookup
2602366Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
8b660f68-b770-4e0a-b2f9-25e663deecc3Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
77dc03a4-fbfc-e6a3-fe95-285bbae40d75Product name220250814
6b7ab8f1-bb38-4c30-8b8b-003c0fe639eaProduct name120250303
0976ea44-ea26-403d-a39d-71fffc6a3d33Product name420250225
f15e8921-7cd5-4c00-9cde-9fa0c9eaca68Product name120231013
0bb393b5-af67-4798-84a7-b797956b02a5Product name120230830
7ea5dc07-b4d4-439d-8145-a10a534148e7Product name120230320
a620f3f0-1e13-41d6-a838-d5407971d39eProduct name120230313
8766e415-735a-4d2c-b173-894ecced3fd9Product name120230308
0ca1d589-929b-4b33-bc5b-1d84abdafa6aProduct name120150324
fc363c46-397b-4476-ac0f-70e43e8e4592Product name120150324

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0480-4516-01Pemetrexed4 mL in 1 VIAL, SINGLE-DOSESOLUTION, CONCENTRATE411
0480-4516-01Pemetrexed1 in 1 CARTONSOLUTION, CONCENTRATE111

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0480-4516-01ML - Milliliter0480-4516acddfced-e498-40a1-bdb0-5926ee8a1a0d12022-06-06

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0480-4516PEMETREXED SOLUTION, CONCENTRATE [TEVA PHARMACEUTICALS, INC.]11Current NDC, Legacy NDC, 2 package rows20241109_8b660f68-b770-4e0a-b2f9-25e663deecc3.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
PemetrexedPEMETREXEDTeva Pharmaceuticals, Inc.8b660f68-b770-4e0a-b2f9-25e663deecc32022-12-01Warnings, Adverse reactionsExact identifier
application applno (NDA): 208419
application number: NDA208419
ndc (product): 0480-4516

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
2602365PEMEtrexed 1 GM in 40 ML InjectionPSN8b660f68-b770-4e0a-b2f9-25e663deecc311
2602366PEMEtrexed 100 MG in 4 ML InjectionPSN8b660f68-b770-4e0a-b2f9-25e663deecc311
2602363PEMEtrexed 500 MG in 20 ML InjectionPSN8b660f68-b770-4e0a-b2f9-25e663deecc311
260236320 ML pemetrexed 25 MG/ML InjectionSCD8b660f68-b770-4e0a-b2f9-25e663deecc311
26023664 ML pemetrexed 25 MG/ML InjectionSCD8b660f68-b770-4e0a-b2f9-25e663deecc311
260236540 ML pemetrexed 25 MG/ML InjectionSCD8b660f68-b770-4e0a-b2f9-25e663deecc311
2602365pemetrexed (as monohydrate) 1 GM per 40 ML InjectionSY8b660f68-b770-4e0a-b2f9-25e663deecc311
2602366pemetrexed (as monohydrate) 100 MG per 4 ML InjectionSY8b660f68-b770-4e0a-b2f9-25e663deecc311
2602363pemetrexed (as monohydrate) 500 MG per 20 ML InjectionSY8b660f68-b770-4e0a-b2f9-25e663deecc311

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
0480-4516-01004804516011 VIAL, SINGLE-DOSE in 1 CARTON (0480-4516-01) / 4 mL in 1 VIAL, SINGLE-DOSE2022-06-010000-00-00NoNoCurrent